Biotech by today's price change
How far the share price has moved since the previous close.
Repligen leads the 24 biotech ranked by today's price change, at +5.00%, ahead of Scholar Rock Holding (+4.43%) and CRISPR Therapeutics (+3.06%). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Repligen+5.00%
- Median
- -0.13%
- Combined market value
- ZAR 14.48T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | RepligenRGEN · Health Care | +5.00% | ZAR 187.2B | ZAR 2,929.09 | 5.00% up | 5% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | +4.43% | ZAR 98.8B | ZAR 809.74 | 4.43% up | 14% up | ||
| 3 | CRISPR TherapeuticsCRSP · Health Care | +3.06% | ZAR 69B | ZAR 711.78 | 3.06% up | 21% down | ||
| 4 | Krystal BiotechKRYS · Health Care | +1.52% | ZAR 154.5B | ZAR 5,213.40 | 1.52% up | 46% up | ||
| 5 | Twist BioscienceTWST · Health Care | +1.20% | ZAR 132.9B | ZAR 1,949.57 | 1.20% up | 340% up | ||
| 6 | argenxARGX · Health Care | +1.07% | ZAR 1.04T | ZAR 16,473.49 | 1.07% up | 4% up | ||
| 7 | ImmunovantIMVT · Health Care | +0.38% | ZAR 118.7B | ZAR 573.40 | 0.38% up | 43% up | ||
| 8 | Kymera TherapeuticsKYMR · Health Care | +0.25% | ZAR 178.9B | ZAR 2,095.44 | 0.25% up | 87% up | ||
| 9 | Bio-TechneTECH · Health Care | +0.14% | ZAR 196.5B | ZAR 1,251.04 | 0.14% up | 26% up | ||
| 10 | ExelixisEXEL · Health Care | +0.09% | ZAR 287.8B | ZAR 1,179.31 | 0.09% up | 63% up | ||
| 11 | BiogenBIIB · Health Care | -0.10% | ZAR 637.1B | ZAR 4,309.74 | 0.10% down | 49% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | -0.13% | ZAR 188B | ZAR 1,648.64 | 0.13% down | 37% up | ||
| 13 | QiagenQGEN · Health Care | -0.13% | ZAR 176.5B | ZAR 854.64 | 0.13% down | 12% up | ||
| 14 | BioNTechBNTX · Health Care | -0.20% | ZAR 361.2B | ZAR 1,456.76 | 0.20% down | 16% down | ||
| 15 | Adaptive BiotechnologiesADPT · Health Care | -0.35% | ZAR 79.1B | ZAR 488.34 | 0.35% down | 88% up | ||
| 16 | Kodiak SciencesKOD · Health Care | -0.41% | ZAR 108.4B | ZAR 1,658.19 | 0.41% down | 396% up | ||
| 17 | Gilead SciencesGILD · Health Care | -0.68% | ZAR 3.61T | ZAR 2,908.88 | 0.68% down | 33% up | ||
| 18 | Neurocrine BiosciencesNBIX · Health Care | -0.72% | ZAR 286.8B | ZAR 2,833.37 | 0.72% down | 20% up | ||
| 19 | VaxcytePCVX · Health Care | -1.09% | ZAR 160B | ZAR 1,010.56 | 1.09% down | 22% up | ||
| 20 | CG OncologyCGON · Health Care | -1.12% | ZAR 119.9B | ZAR 1,342.63 | 1.12% down | 85% up | ||
| 21 | ImmunityBioIBRX · Health Care | -1.76% | ZAR 112.5B | ZAR 105.79 | 1.76% down | 193% up | ||
| 22 | AmgenAMGN · Health Care | -1.85% | ZAR 4.18T | ZAR 7,731.55 | 1.85% down | 34% up | ||
| 23 | ModernaMRNA · Health Care | -2.08% | ZAR 1.41T | ZAR 3,483.31 | 2.08% down | 755% up | ||
| 24 | Revolution MedicinesRVMD · Health Care | -2.52% | ZAR 590B | ZAR 2,728.01 | 2.52% down | 131% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2011 ZAR).
Questions and answers
Which biotech rank first by today's price change?
Repligen (+5.00%), Scholar Rock Holding (+4.43%) and CRISPR Therapeutics (+3.06%) are the top three of the 24 biotech ranked by today's price change as of 18 Nov 2026, 14:51 UTC.
How many biotech are in this ranking?
24 are ranked by today's price change.
What are these biotech worth together?
The 24 biotech ranked by today's price change have a combined market value of ZAR 14.48T as of 18 Nov 2026, 14:51 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.